A detailed history of Gen Trust, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Gen Trust, LLC holds 295,246 shares of KRON stock, worth $280,483. This represents 0.01% of its overall portfolio holdings.

Number of Shares
295,246
Previous 295,246 -0.0%
Holding current value
$280,483
Previous $366,000 19.4%
% of portfolio
0.01%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.73 - $1.38 $215,529 - $407,439
295,246 New
295,246 $366,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $53.9M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Gen Trust, LLC Portfolio

Follow Gen Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gen Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gen Trust, LLC with notifications on news.